
Michael Hoffman @michaelhoffman.bsky.social
@michaelhoffman
Followers
23K
Following
154K
Media
4K
Statuses
79K
Chair, Comp Bio & Medicine Program, Princess Margaret Cancer Centre, @UHN. Assoc Prof, Medical Biophysics, University of Toronto. COI https://t.co/CvupKNIjZr
Toronto
Joined May 2008
I don't log in here much anymore. Try Bluesky. Also, when I do log in I don't check notifications since they've just been polluted with non-notification stuff I don't want like Elon's latest missive.
1
0
0
Do @TransSee predictions include a model of vehicle bunching? That is, for small-headway routes, a vehicle close to a vehicle ahead should travel more quickly than one behind a vehicle ahead?.
2
0
1
What the fax?! I guess faxing isn’t dead 🤷♂️ Use Dropbox Fax by @DropboxSign to send and receive faxes from anywhere. #DropboxFax
1
0
0
Liveposting on Bluesky: @VanAllenLab: The precision cancer medicine challenge: How do we translate all prior knowledge, and all knowledge about a cancer patient at one point in time to make optimal clinical decision? #AACRprecmed25
0
0
2
Liveposting on Bluesky: Taran Gujral: Harnessing patient tissues and AI for rapid, personalized cancer therapy discovery #AACRprecmed25
0
0
1
Liveposting on Bluesky: Celeste Simon: Exploiting kidney cancer cholesterol metabolism for beneficial new therapies #AACRprecmed25
0
0
0
Liveposting on Bluesky: @KislingerThomas: Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers #AACRprecmed25
0
0
1
Liveposting on Bluesky: Bernhard Küster: Phosphoproteome profiling for clinical decision-making in molecular tumor boards #AACRprecmed25
0
0
0
Liveposting on Bluesky: Chris Jones: Cell states and plasticity define drug sensitivity and resistance in paediatric-type diffuse high-grade glioma patient-derived models #AACRprecmed25
0
0
0
Liveposting on Bluesky: @soragnilab: Patient-derived tumor organoid models to identify drug susceptibilities in rare cancers #AACRprecmed25
0
0
0
Liveposting on Bluesky: @PeterHorak_MD: Integrative multi-omics profiling of rare cancers: charting new pathways for clinical translation #AACRprecmed25
0
0
0
Liveposting on Bluesky: @jesseboehm: AscitesPredict: evaluating therapeutic efficacy using rapid ex vivo high dimensional morphology profiling #AACRprecmed25
0
0
2
Liveposting on Bluesky: Sascha Dietrich: Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies #AACRprecmed25
0
0
2
Liveposting on Bluesky: Coleman Lindsley: Dyanmic assessment in leukemia. What is minimal residual disease and does it matter? #AACRprecmed25
0
0
0
Liveposting on Bluesky: Jeffrey Tyner: Functional omics for novel therapeutic combinations in myeloid malignancies #AACRprecmed25
0
0
4